Neem compound fights pancreatic cancer cells

Neem, a plant long recognized in traditional medicine, is now being studied for its potential to combat pancreatic cancer, a notoriously aggressive disease. Researchers have identified a compound within neem, called gedunin, which exhibits promising activity against pancreatic cancer cells in laboratory settings.

This compound targets key mechanisms driving cancer growth and spread. Studies indicate that gedunin can interfere with the Sonic Hedgehog signalling pathway, which is crucial for tumor development. Furthermore, it appears to promote apoptosis, the natural process of cell death, while potentially offering a gentler alternative to traditional chemotherapy.

While these findings are preliminary and derived from pre-clinical research, they represent an exciting development in the search for more effective cancer treatments. Pancreatic cancer, known for its low survival rates and resistance to many therapies, necessitates novel approaches. Gedunin, derived from neem, could play a role in future treatment strategies or complement existing methods.

Beyond its potential in cancer treatment, neem offers a range of other recognized health benefits. These include potent antibacterial properties, support for skin health, assistance in blood sugar regulation, and immune system boosting capabilities. Neem is available in various forms, but medical consultation is advised before use, particularly for serious conditions.